4//SEC Filing
House David Duane 4
Accession 0001104659-24-105848
CIK 0000921114other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:15 PM ET
Size
5.6 KB
Accession
0001104659-24-105848
Insider Transaction Report
Form 4
House David Duane
SVP, Finance, and PFO
Transactions
- Award
Stock Options (Right to Buy)
2024-10-02+75,000→ 75,000 totalExercise: $2.32Exp: 2034-10-02→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The Options shall vest and become exercisable 25% on August 16th of each of 2025, 2026, 2027, and 2028, in each case subject to continuous service through the applicable vesting date.
Documents
Issuer
Armata Pharmaceuticals, Inc.
CIK 0000921114
Entity typeother
Related Parties
1- filerCIK 0002034219
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:15 PM ET
- Size
- 5.6 KB